Go to Client Portal
NAMSA

Cardiology expertise

500

customized preclinical studies

300

cardiology projects per year

7655

trial subjects

560

trial sites managed

NAMSA has extensive experience with cardiac, cardiovascular, and neurovascular devices and supports a myriad of these project types annually. Our technical specialists and scientists are adept at developing preclinical testing programs and evaluating the biocompatibility and functionality of such devices. Working in close collaboration with our specialists, NAMSA’s product development teams are well-versed and experienced in confronting global regulatory, reimbursement and commercialization challenges head-on to achieve accelerated cardiovascular device development outcomes.

Some of most common projects include: cardiovascular devices for hypertension; cardiac mapping technologies; coronary saphenous vein grafts (SVG); counterpulsation pump devices; heart failure devices; ICD and RCT therapies; left atrial appendage occlusion devices; left ventricular assist devices (adult and pediatric); orbital atherectomy systems; robotic ablation for atrial fibrillation; and therapeutic lead EP and intravascular ultrasound devices.

In addition to thousands of cardiovascular biological safety tests conducted annually, NAMSA has completed over 500 customized preclinical studies worldwide. NAMSA supports over 300 cardiology projects and clinical trials per year, and on average, 40 percent of our clinical studies supported involve cardiology or peripheral vascular devices, including:

  • Arteriotomy closure
  • Beating heart surgery systems
  • Cardiac valve repairs
  • Cardiopulmonary bypass equipment
  • Cardiac catheters
  • Coronary guidewires
  • Cardiac Resynchronisation Therapy (CRT)
  • Coronary stents
  • Cardiac valve repairs
  • Heart valves (mechanical, tissue, transcatheter)
  • Implantable Cardioverter Defibrillators (ICD)
  • Implantable Loop Recorders (ILR)
  • Inferior Vena Cava Filters (IVCF)
  • Intravascular Ultrasound Systems (IVUS)
  • Mechanical circulatory support Pacemakers
  • Perfusion disposables
  • Peripheral thrombectomy
  • PV embolization plugs and coils
  • Transcatheter Mitral Valve Repair (TMVR)

Within the last five years, NAMSA has performed 250 cardiovascular and 50 peripheral vascular projects in 30 countries with:

  • 800 sites
  • 8,000 subjects
  • 5,000 monitoring visits
  • 450 databases built and managed

Cardiovascular Clinical Studies

Cardiovascular Expertise